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Background: Magnolin is a natural compound abundantly found in Magnolia flos, which has been traditionally
used in oriental medicine to treat headaches, nasal congestion and anti-inflammatory reactions. Our recent results
have demonstrated that magnolin targets the active pockets of ERK1 and ERK2, which are important signaling
molecules in cancer cell metastasis. The aim of this study is to evaluate the effects of magnolin on cell migration
and to further explore the molecular mechanisms involved.
Methods: Magnolin-mediated signaling inhibition was confirmed by Western blotting using RSK2+/+ and RSK2−/−
MEFs, A549 and NCI-H1975 lung cancer cells, and by NF-κB and Cox-2 promoter luciferase reporter assays.
Inhibition of cell migration by magnolin was examined by wound healing and/or Boyden Chamber assays using
JB6 Cl41 and A549 human lung cancer cells. The molecular mechanisms involved in cell migration and
epithelial-to-mesenchymal transition were determined by zymography, Western blotting, real-time PCR and
immunocytofluorescence.
Results: Magnolin inhibited NF-κB transactivation activity by suppressing the ERKs/RSK2 signaling pathway.
Moreover, magnolin abrogated the increase in EGF-induced COX-2 protein levels and wound healing. In
human lung cancer cells such as A549 and NCI-H1975, which harbor constitutive active Ras and EGFR
mutants, respectively, magnolin suppressed wound healing and cell invasion as seen by a Boyden chamber
assay. In addition, it was observed that magnolin inhibited MMP-2 and −9 gene expression and activity. The
knockdown or knockout of RSK2 in A549 lung cancer cells or MEFs revealed that magnolin targeting ERKs/
RSK2 signaling suppressed epithelial-to-mesenchymal transition by modulating EMT marker proteins such as
N-cadherin, E-cadherin, Snail, Vimentin and MMPs.
Conclusions: These results demonstrate that magnolin inhibits cell migration and invasion by targeting the
ERKs/RSK2 signaling pathway.Background
Magnolin is the major component abundantly found in
the dried buds of the magnolia flower, Shin-Yi, which
has been traditionally used as an oriental medicine to
treat nasal congestion associated with headaches, sinus-
itis, inflammation, and allergic rhinitis [1]. A previous
study has indicated that topical application of the Mag-
nolia flos (flosculous: a small budding flower) extract in-
hibits passive cutaneous anaphylaxis induced by anti-
dinitrophenyl (DNP) IgE in rats [2]. Recent studies have* Correspondence: yongyeon@catholic.ac.kr
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tumor necrosis factor-α (TNF-α) and prostaglandin E2
(PGE2) by inhibiting extracellular signal-regulated ki-
nases (ERKs) [3, 4], which are key signaling molecules in
the regulation of cell proliferation, transformation [5]
and cancer cell metastasis [6]. Our previous results
have demonstrated that magnolin targeting ERK1
(IC50 87 nM) and ERK2 (IC50 16.5 nM) inhibits cell
transformation induced by tumor promoters such as
epidermal growth factor (EGF) [5]. To date, no direct
evidence regarding the inhibitory effects of magnolin
on metastasis has been provided.istributed under the terms of the Creative Commons Attribution 4.0
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a family of serine/threonine kinases activated by the
Ras/MEKs/ERKs signaling pathway, which responds to
diverse extracellular stimuli [7]. RSK2 is a member of
the RSK family and is phosphorylated at the C-terminal
kinase and linker domains by ERK1/2 [8] and at the N-
terminal kinase domain by phosphoinositide-dependent
kinase 1 (PDK1) [9]. Activated RSK2 transduces its acti-
vation signal to various downstream target proteins in-
cluding transcription and epigenetic factors [10–12],
kinases [13], and scaffolding proteins such as nuclear
factor of κ light polypeptide gene enhancer in B-cells in-
hibitor α (IκBα) [14], and regulates diverse cellular activ-
ities involved in cell proliferation, transformation and
motility [15]. For instance, our previous results have
demonstrated that the enhanced cAMP-dependent tran-
scription factor 1 (ATF1) activity, caused by the epider-
mal growth factor (EGF)-mediated Ras/ERKs/RSK2
signaling pathway, induces cell proliferation and trans-
formation [16]. The increased NF-κB transactivation ac-
tivity, resulting from the RSK2-IκBα signaling pathway,
modulates cell survival induced by the FAS-mediated
death signaling pathway [13]. A recent report demon-
strates that RSK2 promotes the invasion and metastasis
of head and neck squamous cell carcinoma cells in
humans [17]. Therefore, the Ras/ERKs/RSK2 signaling
axis may be a key signaling pathway in the regulation of
cell proliferation and transformation, and in cancer cell
metastasis.
Nuclear factor-κB (NF-κB) is a ubiquitous nuclear
transcription factor composed of p65 (Rel A), p68 (Rel
B), p75 (c-Rel), p50 and p52 [18]. In the absence of cel-
lular stimulation, NF-κB is located in the cytoplasm and
forms a complex with specific inhibitors of NF-κB
(IκBs). Upon cell stimulation by growth factors and pro-
inflammatory cytokines, IκBα is phosphorylated by IκBα
kinase (IKK), leading to ubiquitination and degradation
[19]. Following degradation of IκBα, NF-κB translocates
to the nucleus and effects the expression of genes in-
volved in cell proliferation, invasion and metastasis [19].
Recently, we identified an alternative signaling pathway
regulating NF-κB activation, in which RSK2 phosphory-
lates IκBα at Ser32, promoting the ubiquitination-
mediated degradation of IκBα [20]. Due to the fact that
ERK1 and 2 are direct upstream kinases of RSK2 [8], tar-
geting ERK1/2 with small molecules may be the focus in
the development of a drug acting as a metastatic
inhibitor.
The mitogen-activated protein kinase (MAPK) family
is comprised of three subfamilies including ERKs, p38
kinases and c-Jun N-terminal kinases (JNKs), which
play a key role in the regulation of cellular respon-
siveness by the diverse extracellular stimuli such as
growth factors, peptide hormones, and environmentalstressors such as ultraviolet light [13, 21, 22]. The
ERKs/RSK2 signaling axis plays a pivotal role in cell
proliferation, differentiation, survival, and transform-
ation [8, 10, 13, 15, 21], in addition to cell migration
through the induction of matrix metalloproteinases
(MMPs), which are the enzymes that degrade the
extracellular matrix, such as collagen and gelatin, to
facilitate the metastasis of cancer cells [6]. Recently,
our research group found that magnolin, a major
component of Magnolia flos (Shin-Yi) that has been
traditionally used as an oriental medicine to treat
headaches, nasal congestion and inflammatory reac-
tions [23], inhibits the Ras/ERKs/RSK2 signaling axis
by targeting the active pocket of ERK1 and ERK2 with
IC50 values of 87 nM and 16.5 nM, respectively [5].
Furthermore, we found that AP-1 and NF-κB transac-
tivation activities were downregulated by the inhibition
of ERK1/2-mediated RSK2 activity [5, 20], suggesting
that magnolin may suppress the gene expression of
Cox-2, an enzyme that plays an important role in can-
cer cell proliferation, motility and metastasis [24].
Generally, metastasis is complicated multiple biological
processes including 1) loss of adhesion involved during
epithelial to mesenchymal transition (EMT), 2) in-
creased motility and invasiveness to achieve intravasa-
tion, 3) circulation through blood vessels and lymph
nodes, and 4) attachment to blood vessels followed by
extravasation [25]. Eventually, the metastatic cancer
cells succeed in colonizing on distant organ tissues,
which causes more than 90 % of cancer deaths [26].
However, the molecular mechanisms behind magnolin-




Chemical reagents such as NaCl, Tris, sodium dodecyl
sulfate (SDS) and buffer preparations were purchased
from Sigma-Aldrich chemical Co. (St. Louis, MO, USA).
Recombinant EGF was purchased from BD Sciences
(San Jose, CA, USA). Antibodies against phospho-IκBα,
total-IκBα, N-cadherin, β-actin, MMP-2, MMP-9, E-
cadherin, COX-2, and total-RSK2 were purchased from
Cell Signaling Technology (Beverly, MA, USA), Santa
Cruz Biotechnology (Santa Cruz, CA, USA) and Thermo
Fisher Scientific Inc. (Waltham, MA, USA). Cell culture
media and other supplements were purchased from Life
Science Technology (Rockville, MD, USA) and Corning
(Corning, NY, USA).
Magnolin
Magnolin was extracted from the dried flower buds of
Magnolia fargesii in accordance with the method estab-
lished by Lee et al., (Korea Patent # 10-0321212-0000)
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performance liquid chromatography (HPLC), which was
generously provided by Dr. SR Oh of the Korean
Research Institute of Bioscience and Biotechnology
(KRIBB). Magnolin was prepared as a stock solution
(100 mM: 1000X) by dissolving in DMSO obtained from
Sigma-Aldrich Co. LLC., (St. Louis, MO, USA), after
which it was aliquoted and stored at −20 °C. The mag-
nolin was freshly diluted in DMSO before utilization,
and the cells were treated upon medium exchange with
magnolin premixed cell culture medium, in which the
DMSO concentration did not exceed 0.1 % of the total
volume.
Cell culture and transfection
JB6 Cl41 cells purchased from ATCC were cultured with
5 % FBS-MEM, and RSK2+/+ and RSK2−/− mouse em-
bryonic fibroblasts (MEFs) were cultured with 10 %
FBS-DMEM, containing penicillin/streptomycin, at
37 °C in a 5 % CO2 incubator. All animal experimental
protocols were approved by the Institutional Animal Care
and Use Committee at the Catholic University of Korea
(approval number: 2014–0046). A549 and NCI-H1975 hu-
man lung cancer cells, purchased from ATCC, were cul-
tured with 10 % FBS-F12K and 10 % FBS-RPMI 1640,
respectively, according to the guidelines of Institutional
Laboratory Safety. The cells were maintained by passage
at 80-90 % confluence, and the media was changed every
other day. Transfection of the various expression vectors
was carried out using jetPEI (Polyplus-Transfection Inc.,
New York, NY, USA) according to the manufacturer’s
protocol.
Cell migration and invasion assay
JB6 Cl41 (7 × 104), A549 (7 × 104) and NCI-H1975
(7 × 104) cells, and RSK2+/+ (7 × 104) and RSK2−/− (7 × 104)
MEFs were seeded into culture-inserts (ibidi GmbH,
Martinsried, Germany) and cultured overnight. The cells
were treated with mitomycin-C (10 μg/ml) for 2 h, and
the culture-inserts were removed to offer a cell-free gap.
The cells were treated with the indicated doses of mag-
nolin either in the presence or absence of EGF for 12 or
24 h, and cell migration was observed under a light
microscope. The migrated area was measured using the
Image J computer software program (v. 1.45). To meas-
ure the magnolin effect on cancer cell invasion, a
matrigel-coated invasion chamber (Corning Incorporated,
Coring, NY, USA) was used. Briefly, A549 or NCI-H1975
(2.5 × 104) cells were seeded into an insert chamber with
FBS-free media supplemented with the indicated doses of
magnolin, and cultured in 24-well plates supplemented
with complete media for the appropriate time period.
The cells were fixed with 4 % formaldehyde, perme-
abilized with methanol and stained with crystal violet.The stained cells were observed under a light microscope
and those that had migrated were counted.
Gelatin zymography
MMP-2 and −9 activities were evaluated by gelatin
zymography using the cell culture supernatants. Briefly,
A549 cells (4 × 105) were seeded into 60 mm dishes, cul-
tured and treated with the indicated doses of magnolin
for 24 h. The culture supernatants were harvested, and
20 μg of protein from each sample were loaded on a
polyacrylamide gel containing 0.2 % gelatin. The gel was
washed with 2.5 % Triton X-100 buffer for 20 min, and
then incubated for 24 h at 37 °C in renaturing buffer
[50 mM Tris-Cl (pH 7.5), 10 mM CaCl2, 1 μM ZnCl2,
0.01 % NaN3]. The gels were stained with Coomassie
Brilliant Blue and destained in methanol/acetic acid.
Immunocytofluorescence (ICF)
A549 cells (6 × 104) were seeded into 4-chamber slides,
cultured and treated with the indicated doses of magno-
lin for 24 h. The cells were fixed with 4 % formalin,
blocked in 1 % BSA/Tween-20/1X PBS at room
temperature for 1 h, and hybridized with anti-N-
cadherin primary and Flamma Fluors 552- or Alexa-488-
conjugated secondary antibodies (BioActs, Incheon,
Gyeonggi-do, Korea). The slides were mounted with
FluoroshieldTM-DAPI (Sigma-Aldrich, St. Louis, MO,
USA). The N- and E-cadherin protein levels were visual-
ized under a LSM 710 laser scanning confocal micro-
scope (Carl Zeiss, Oberkochen, Germany).
Real-time PCR (RT-PCR)
A549 cells (5 × 105) were seeded into 60 mm dishes, cul-
tured overnight and treated with the indicated doses of
magnolin for 24 h. Total RNA was extracted using Tri-
zol (Invitrogen, Carlsbad, CA, USA), and quantitative
gene expression levels of MMP-2 and −9 were measured
by real-time polymerase chain reaction (PCR) using a
specific primer set, MMP-2 (Hs01548727_m1) and
MMP-9 (Hs00234579_m1), a GAPDH specific real-time
primer set (4352934E), and a TaqMan RNA-to-CT 1-step
kit (applied Biosystems, Foster City, CA, USA) according
to the manufacturer’s recommended protocol. The CT
values of MMP-2 and MMP-9 RNA expression were
normalized to the CT values of GAPDH as an internal
control to ensure equal RNA utilization.
Reporter gene assay
JB6 Cl41 (2 × 104) cells stably expressing an NF-κB- or
Cox-2-promoter luciferase reporter plasmid, and A549
cells (2 × 104) cells stably expressing an MMP-2 or an
MMP-9 promoter luciferase reporter plasmid were
seeded into a 24-well plate and cultured overnight. The
cells were starved for 16 h, pretreated with the indicated
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EGF (10 ng/ml) at the indicated doses of magnolin for
24 h. The cells were disrupted, and the firefly luciferase
activities were measured using a VIXTOR X3 fluoro/
luminometer (Perkin Elmer Inc., Waltham, MA, USA).
Western blotting
Samples containing equal amounts of proteins as indi-
cated were resolved by SDS polyacrylamide gel electro-
phoresis and transferred to PVDF membranes. The
membranes were blocked with 5 % skimmed milk/1X
PBS/0.5 % Tween 20 at room temperature for 1 h, and
hybridized with the specific primary and HRP-
conjugated secondary antibodies as indicated. The pro-
teins were visualized by an enhanced chemiluminescence
(ECL) detection system (Amersham Bioscience Corp.,
Piscataway, NJ, USA).
Results
Magnolin inhibits NF-κB transactivation activity
NF-κB activation plays a key role in cell migration [28].
Our previous results have demonstrated that RSK2 in-
duced the proteasomal degradation of IκBα by phos-
phorylation at Ser32, resulting in activation of NF-κB
transactivation activity [20], and magnolin, a natural
compound abundantly found in Shin-Yi (Fig. 1a and
Additional file 1: Figure S1), inhibited ERK1 and ERK2
[5]. Moreover, RSK2 activity is regulated by ERK1/2 [8].
Therefore, we hypothesized that magnolin may inhibit
cell migration. To examine this hypothesis, we used
RSK2+/+ and RSK2−/− MEFs (Fig. 1b) and confirmed that
RSK2 deficiency abrogated EGF-induced IκBα phosphor-
ylation at Ser32 (Fig. 1b). Notably, magnolin treatment
suppressed EGF-induced IκBα phosphorylation at Ser32
in a dose-dependent manner, and 60 μM magnolin to-
tally abolished EGF-induced IκBα phosphorylation at
Ser32 through the inhibition of RSK phosphorylation
(Fig. 1c). The phosphorylation status at Ser32 and Ser36
of IκBα served as a degron motif for the SCF-βTrCP
ubiquitin E3 ligase complex, which resulted in the deg-
radation of IκBα [19], resulting in NF-κB nuclear
localization [18]. Our results strongly suggest that
magnolin-mediated inhibition of ERK1/2 activity may in-
hibit RSK2-mediated NF-κB transactivation activity. To
determine whether magnolin inhibits NF-κB transactiva-
tion activity, we starved the cells and treated them with
EGF. We found that EGF treatment induced NF-κB
transactivation activity (Fig. 1d). Notably, magnolin
treatment suppressed EGF-induced NF-κB transactiva-
tion activity in a dose-dependent manner (Fig. 1d). Fur-
ther, we found that NF-κB transactivation activity was
inhibited under normal cell culture conditions by mag-
nolin treatment in a dose-dependent manner (Fig. 1e).
These results demonstrate that magnolin inhibitedERK1/2 activity, which resulted in the suppression of
RSK2/NF-κB signaling by inhibiting IκBα phosphoryl-
ation at Ser32.
Magnolin suppresses EGF-induced cell migration in JB6
Cl41 cells
Cyclooxygenase-2 (COX-2) is one of the downstream
targets of NF-κB and plays a key role in inflammation,
tumorigenesis, angiogenesis, invasion and migration
[29]. The cytosolic NF-κB heterodimer complex, com-
posed of p65 (Rel A), p50 and IκBα, was activated by
various stimuli including environmental stresses, cyto-
kines and growth factors [30]. The EGF-mediated sig-
naling pathway induces COX-2 mediated inflammation
and cell migration through RSK2-mediated IκBα des-
tabilization [20, 29]. Recently, we found that magnolin
targeted ERK1 and 2, inhibited their activity with an
approximate IC50 of 87 nM and 16.5 nM, respectively,
and suppressed cell proliferation and neoplastic cell
transformation ex vivo [5]. Thus, we hypothesized that
magnolin may inhibit the proinflammatory regulator
COX-2, and ultimately wound healing. We found that
EGF-induced COX-2 protein levels were suppressed by
magnolin treatment in a dose-dependent manner
(Fig. 2a). Notably, the Cox-2 promoter activity induced
by EGF was abolished by magnolin treatment (Fig. 2b).
Additionally, the Cox-2 promoter activity was also sup-
pressed by magnolin treatment under normal cell cul-
ture conditions (Fig. 2c). Further, we found that JB6
Cl41 cell migration enhanced by EGF treatment was dra-
matically suppressed by magnolin treatment in a dose-
dependent manner (Fig. 2d). Our previous results have
demonstrated that magnolin suppressed RSK2 activity
by inhibiting ERK1/2-mediated-RSK2 phosphorylation at
a linker region and a C-terminal kinase domain [5].
Taken together, our results demonstrate that magnolin
inhibited ERK1/2/RSK2 signaling-mediated IκBα phos-
phorylation at Ser32, resulting in the inhibition of NF-
κB activation and cell migration.
Magnolin inhibits migration and invasion of human lung
cancer cells
Our previous study indicated that magnolin inhibited
cell proliferation of A549 cells [5], a human lung cancer
cell line harboring metastatic capabilities such as inva-
sion and migration [5, 31]. Therefore, we hypothesized
that magnolin may suppress the metastatic capabilities
of lung cancer cells such as A549 and NCI-H1975 cells.
To examine this hypothesis, we conducted a wound
healing assay. We found that cell migration into a cell-
free gap was inhibited by magnolin treatment approxi-
mately 50 % ~ 80 % at 30 μM and 60 μM in A549 cells
and 50 % at 60 μM magnolin in NCI-H1975 cells (Fig. 3a
and Additional file 2: Figure S2A). Moreover, we found
Fig. 1 Magnolin inhibits NF-κB transactivation activity. a Chemical structure of magnolin. b RSK2 mediates IκBα phosphorylation at Ser32. RSK2+/+
and RSK2−/− MEFs were used to visualize the phosphorylation of IκBα induced by EGF stimulation using the specific antibodies as indicated. c
Magnolin inhibits EGF-induced IκBα phosphorylation at Ser32. JB6 Cl41 (1 × 106) cells were seeded, starved, and treated with magnolin in the
presence or absence of EGF. The specific protein levels were visualized by Western blotting using the specific antibodies as indicated. b–c β-actin
was used as an internal control to verify equal protein loading. d–e Magnolin inhibits EGF-induced NF-κB transactivation activity. JB6 Cl41 cells
stably expressing NF-κB luciferase reporter plasmid were seeded, cultured, starved, and stimulated with EGF and the indicated doses of magnolin
(d), or treated with the indicated doses of magnolin under normal culture conditions for 24 h (e). Firefly luciferase activity was measured as
described in “Materials and Methods”. b–e Data are presented as the mean ± S.D. of values from triplicate experiments, and statistical significance
was determined using the Student’s t-test (*, p < 0.05)
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indicated that magnolin suppressed cancer cell invasion
in a dose dependent manner in both human lung cancercells (Fig. 3b and Additional file 2: Figure S2B). Recently,
the MEK inhibitor PD98059 has been shown to dramat-
ically suppress the activities and gene expressions of
Fig. 2 Magnolin suppresses EGF-induced cell migration in JB6 Cl41 cells. a Magnolin inhibits COX-2 protein levels. JB6 Cl41 cells were starved,
treated with the indicated doses of magnolin and EGF for 30 min, and then the COX-2 protein level was visualized by Western blotting. β-actin
was used as an internal control to verify equal protein loading. b–c Magnolin suppressed EGF-induced Cox-2 promoter activity. JB6 Cl41 cells
stably expressing Cox-2-promoter luciferase reporter plasmid were seeded, cultured, starved and the luciferase activities analyzed for the Cox-2
promoter activity by combination treatment with EGF and magnolin as indicated (b), or the Cox-2 gene expression was analyzed with magnolin
treatment under normal cell culture conditions for 24 h (c) as described in “Materials and Methods”. d Magnolin inhibits EGF-induced cell
migration. JB6 Cl41 cells were seeded into culture-inserts and cultured overnight. Cell proliferation was stopped by mitomycin-C treatment for
2 h, and culture inserts were removed to offer a cell-free gap. The cells were treated with EGF or EGF and magnolin for 24 h, cell migration was
observed under a microscope, and then the migrated area was measured using the Image J computer software program (v. 1.45). a–d Data are
presented as the mean ± S.D. of values from triplicate experiments, and statistical significance was determined using the Student’s t-test
(*, p < 0.05)
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magnolin may modulate MMP-2 and −9 activities by
suppression of gene expression. To examine these hy-
potheses, we collected cell culture medium and analyzedMMP-2 and −9 activities by zymography. We found that
secreted MMP-2 and −9 activities were decreased by
magnolin in a dose-dependent manner (Fig. 3c). More-
over, MMP-2 and −9 protein levels in the cells were
Fig. 3 Magnolin inhibits migration and invasion of human lung cancer cells. a Magnolin inhibits cell migration. A549 or NCI-H1975 cells
were seeded into culture-inserts and treated with mitomycin-C. The culture-inserts were removed, the cell migration was measured using
the Image J computer software program (v. 1.45), followed by treatment with the indicated doses of magnolin for 24 h. b Magnolin
inhibits cancer cell invasion. A549 and NCI-H1975 cells were seeded into the inserts of Boyden chambers and cultured overnight. The
cells were treated with the indicated doses of magnolin, and cell invasion was allowed for 24 h. The migrated cells were stained with
crystal violet, observed and counted under an inverted microscope. c Magnolin suppresses the activity of MMP-2 and MMP-9. A549 cells
(5 × 105) were seeded, cultured, and treated with the indicated doses of magnolin for 24 h. The cultured media was harvested for
zymography as described in “Materials and Methods”. d Magnolin reduces the protein levels of MMP-2 and −9. MMP-2 and −9 protein
levels from (c) were visualized by Western blotting using the specific antibodies as indicated. β-actin was used as an internal control to
verify equal protein loading. e Magnolin inhibits the gene expression of MMP-2 and −9. The MMP-2 and −9 mRNA levels from the cells
in (c) were analyzed by real-time PCR as described in “Materials and methods”. f Magnolin suppresses the promoter activities of MMP-2
and −9. A549 cells stably expressing MMP-2 or MMP-9 promoter luciferase reporter plasmid were seeded, cultured, and treated with the
indicated doses of magnolin for 24 h. Firefly luciferase activity was measured as described in “Materials and Methods”. a–f Data are
presented as the mean ± S.D. of values from triplicate experiments, and statistical significance was determined using the Student’s t-test
(*, p < 0.05)
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the magnolin concentration (Fig. 3d). These results were
firmly supported by the reproducible COX-2 protein
levels that magnolin inhibited through the suppression
of Cox-2 gene expression (Fig. 2a–c). To examine the
casual reasons for the decrease in MMP-2 and −9 pro-
tein levels, we conducted real-time PCR using MMP-2
and MMP-9 specific primer sets and found that the gene
expression of MMP-2 and −9 was inhibited by magnolin
treatment (Fig. 3e). Simultaneously, we found that the
promoter activities of MMP-2 and −9 were suppressed
by magnolin treatment in a dose-dependent manner
(Fig. 3f ). These results demonstrate that magnolin sup-
presses cell migration and invasion in human lung can-
cer cells.
Magnolin inhibits epithelial-to-mesenchymal transition
In order to metastasize, cancer cells are required to
change their behavior [25]. Colonized cancer cells in tu-
mors dissociate by transitioning from epithelial cells into
cells that have mesenchymal properties [35]. The
processes are mediated by the alteration of adhesion
molecules such as E-cadherin, an epithelial marker, and
N-cadherin, a mesenchymal marker [35]. Our results
demonstrate that magnolin suppressed cell migration
and invasion (Figs. 2 and 3). These results strongly
suggest that magnolin may modulate epithelial-to-
mesenchymal transition. To examine this hypothesis, we
conducted Western blotting and found that magnolin
enhanced E-cadherin and suppressed N-cadherin protein
levels in A549 lung cancer cells (Fig. 4a). Notably, the
protein levels of EMT marker proteins such as Snail and
Vimentin were decreased by magnolin treatment in a
dose-dependent manner (Fig. 4a). Immunocytofluores-
cence data clearly demonstrated that magnolin abolished
the epithelial-to-mesenchymal transition in A549 lung
cancer cells (Fig. 4b). However, we could not find a cell
morphological change induced by magnolin (Additional
file 3: Figure S3). To analyze the RSK2 involvement in
EMT, we utilized RSK2 knockdown cells using RSK2 sh-
RNA and found that RSK2 knockdown suppressed
wound healing of A549 lung cancer cells (Fig. 4c, graph,
and Additional file 4: Figure S4A). Interestingly, RSK2
knockdown by RSK2 sh-RNA suppressed N-cadherin
and MMP-2 protein levels, and enhanced E-cadherin
protein levels without dramatic alteration of Snail and
Vimentin protein levels (Fig. 4c, Western blotting), but
with a morphological change of A549 cells (Additional
file 4: Figure S4B). Importantly, RSK2 deficiency abro-
gated the cell migration induced by EGF compared with
RSK2+/+ MEFs (Fig. 4d, graph, and Additional file 4:
Figure S4C). The EMT marker proteins including
Vimentin, MMP-2, and N-cadherin were highly de-
tected in RSK2+/+ MEFs, with E-cadherin beinghardly detected, and Snail was slightly decreased in
RSK2−/− MEFs (Fig. 4d, Western blotting). These re-
sults strongly support the notion that magnolin sup-
presses cell migration and invasion by targeting the
ERKs/RSK2 signaling pathway.
Discussion
Oriental medicinal herbs contain many useful com-
pounds, and have been widely used to identify novel com-
pounds that may have therapeutic value in the treatment
of human diseases. For instance, myricetin and quercetin
from dietary herbs and epigallocatechin gallate from green
tea inhibit cell proliferation and transformation [36],
highlighting the importance of efforts to identify natural
compounds that inhibit the ERKs/RSKs signaling pathway,
while suppressing the MAPK pathway in a non-toxic
manner [37]. Early buds of the magnolia flower are an
oriental medicinal herb and traditionally used to treat
inflammation-mediated human diseases including empy-
ema, nasal congestion, sinusitis and allergic rhinitis [1].
Recent reports have provided evidence that magnolin in-
hibits the expression of cell adhesion molecules including
intercellular adhesion molecule-1 and vascular cell adhe-
sion molecule-1 [38]. However, although magnolin has
shown diverse effects on human diseases, the molecular
targets of magnolin had not yet been identified. Recently,
our research group found that ERK1 and ERK2 are the
molecular targets of magnolin, which inhibited their kin-
ase activity with IC50 values of 87 nM and 16.5 nM, re-
spectively, by competing with ATP in an active pocket [5].
Furthermore, our previous results have demonstrated that
ERK1/2-mediated RSK2 activation modulates NF-κB ac-
tivity by phosphorylation of IκBα at Ser32 [20]. These re-
sults provide us with the rationale to consider that
magnolin may show effectiveness on cell migration and
cancer metastasis. In pancreatic cancer, the NF-κB signal-
ing pathway plays an important role in EMT and metasta-
sis [39, 40]. Moreover, NF-κB activation induces classical
EMT marker changes and the promotion of cell migration
and invasion [41], indicating that ERK/RSK2/NF-κB sig-
naling may play a key role in cell migration and invasion.
Our results support the notion that RSK2 activity modu-
lates NF-κB activity (Fig. 1c and d). Importantly, the
knockdown and knockout of RSK2 attenuated cell migra-
tion (Fig. 4c and d), which was similarly observed upon
magnolin treatment of A549 and NCI-H1975 lung cancer
cells (Fig. 3a and b). These results demonstrate that ERK
inhibition by magnolin suppresses RSK2-mediated NF-κB
activity, resulting in suppression of cell migration and in-
vasion in cancer cells.
The cellular program called EMT is accompanied
by profound changes in cell characteristics that enable
the epithelial cells to detach from tight junctions,
change the cell’s shape and polarity, delaminate, and
Fig. 4 Magnolin inhibits epithelial-to-mesenchymal transition. a Effects of magnolin on the protein levels of epithelial-mesenchymal marker
proteins. A549 cells were seeded, cultured, treated with the indicated doses of magnolin for 24 h. The proteins were extracted and visualized by
Western blotting using the specific antibodies as indicated. b Effects of magnolin on the N- and E-cadherins by immunocytofluorescence analysis
in A549 cells. The protein levels of N- and E-cadherins altered by magnolin treatment were visualized by immunocytofluorescence as described in
“Materials and Methods”. c RSK2 knockdown effects on the protein levels of EMT marker proteins. Graph, knockdown of RSK2 inhibits cell
migration in A549 cells. A549 cells stably expressing sh-mock or sh-RSK2 were seeded into culture-inserts and treated with mitomycin-C for 2 h.
The culture-inserts were removed, and the cell migration was measured 24 h later using the Image J computer software program (v. 1.45). Panels,
A549 cells stably expressing sh-mock or sh-RSK2 were seeded, cultured and harvested. The protein levels were visualized by Western blotting
using the specific antibodies as indicated. d RSK2 deficiency suppresses cell migration and EMT marker protein levels. Graph, RSK2+/+ mesenchymal
and RSK2−/− MEFs were seeded into culture-inserts and treated with mitomycin-C for 2 h. The culture-inserts were removed, treated with 10 ng/ml EGF
and cell migration was allowed for 24 h. The cell migration was observed and measured using the Image J computer software program (v. 1.45). Panels,
RSK2+/+ and RSK2−/− MEFs were seeded, cultured and harvested. The proteins were extracted and visualized by Western blotting using the specific
antibodies as indicated. a, c and d β-actin was used as an internal control to verify equal protein loading. Data are presented as the mean ± S.D. of
values from triplicate experiments, and statistical significance was determined using the Student’s t-test (*, p < 0.05)
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signaling pathways have been associated with EMT
induction, including EGF through the JAK pathway
and the ERK/MAPK signaling pathway [43, 44]. Previ-
ous reports have indicated that coffee or chlorogenic
acid abolished CT-26 metastasis to the lung byblocking ERK/AP-1 and ERK/NF-κB signaling path-
ways [45]. Our results demonstrate that EGF stimula-
tion induces cell migration in JB6 Cl41 cells (Fig. 2d).
The role of RSK2 in EGF-induced cell migration was
confirmed using RSK2+/+ and RSK2−/− MEFs, that
RSK2 deficiency abrogated EGF-induced wound
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confirmed that knockdown of RSK2 using RSK2 sh-
RNA suppressed cell migration (Fig. 4c). Interestingly,
we found that RSK2 knockdown inhibited MMP-2
and N-cadherin and enhanced E-cadherin (Fig. 4c),
however, unexpectedly, there were no significant
changes observed in Snail and Vimentin (Fig. 4c).
Similar results were observed with Snail, but not with
Vimentin, in RSK2+/+ and RSK2−/− MEFs (Fig. 4d).
The gene expression of Snail is dependent on ERKs
activity through the ERK/Fra-1/c-Jun signaling path-
way [46] and the ERK/ELK-1 signaling pathway [47].
Our previous results have demonstrated that RSK2
deficiency dramatically increased total protein levels
and phosphorylation sensitivity of ERK1/2 by EGF
treatment [13]. Thus, we suggest that the no change
in Snail is due to the reactivation of ERKs by the ac-
tivation of the RSK2 feedback loop. Based on this hy-
pothesis, it is possible to explain that magnolin
inhibited cell migration and invasion by downregulat-
ing ERK-mediated Vimentin protein level by downreg-
ulating the RSK2-mediated NF-κB signaling pathway.
Taken together, these results demonstrate that RSK2
mediates EGF-induced cell migration signaling through
the ERKs/RSK2 signaling pathway.
The wound healing assay is a well-adapted strategy to
evaluate cancer cell metastasis ex vivo [48]. The RSK2
function in cancer metastasis has been observed from
head and neck squamous cell carcinoma (HNSCC) in
cancer patients [17]. This evidence was proved by a
xenograft metastasis experiment showing that knock-
down of RSK2, but not RSK1, reduced the metastasis of
human HNSCC cells [17]. Furthermore, RSK protein
levels are important in determining whether cancer cells
have the capability to metastasize. RSK1-silencing en-
hances in vitro cell migration, and human patient sam-
ples of metastatic lung cancer have lower RSK1
expression levels compared with non-metastatic cancer
tissues [49]. In contrast, cancer tissue analysis from
HNSCC showed a positive relationship between the
metastatic ability and RSK2 protein levels [49]. Our pre-
vious results have demonstrated that total- and
activated-RSK2 protein levels were observed in a human
tissue array of skin cancers [8, 22]. Importantly, our
ex vivo study demonstrated that RSK2 protein levels
were more enhanced in skin cancer cells such as malig-
nant melanoma compared with squamous cell carcin-
oma and premalignant immortalized cells [22]. The
signaling study of RSK2 indicates that RSK2 can phos-
phorylate GSK3β at Ser9, resulting in enhanced cell sur-
vival from stresses such as calcium and UV irradiation
[13]. Due to the fact that RSK2 is phosphorylated by
ERK1 and 2, but not by p38 kinase, ERK1 and 2 inhibi-
tors may be useful compounds to inhibit cancer cellmetastasis. Magnolin is a potent natural compound, hav-
ing strong inhibitory effects on ERK1 and 2 by compet-
ing with ATP in the active pockets [5], and we believe
that magnolin has a potential application in human can-
cer prevention and metastasis.
Conclusions
This study demonstrates that the inhibition of ERKs/
RSK2 signaling by magnolin, a natural compound from
dried Magnolia flos that has long been used as a trad-
itional oriental medicine, abrogated the epithelial-to-
mesenchymal transition and cell migration and invasion.
The effects of magnolin on cell migration facilitated
through NF-κB-mediated Cox-2 gene expression were
by inhibition of ERKs/RSK2 signaling. Simultaneously,
our results demonstrate that magnolin inhibited the ac-
tivity of MMP-2 and MMP-9, which are critical enzymes
involved in cell migration and focal adhesion. Notably,
magnolin suppressed the epithelial-to-mesenchymal
transition. This is the first report to demonstrate the role
of magnolin as a metastatic inhibitor in lung cancer
cells. As part of future research, these results may be-
come a mechanism-driven foundation for the identifica-
tion of natural compounds potentiating cancer
therapeutic efficacy or cancer chemoprevention.
Additional files
Additional file 1: Figure S1. HPLC chromatogram of magnolin. The
mobile phase for HPLC consisted of solvent A, deionized water, and
solvent B, 100 % methanol. The solvent gradient was as follows: 0 min,
50 % B; 50 min, 75 % B; 51 min, 98 % B, 55 min, 98 % B, and then held
for 10 min before returning to the initial conditions. The flow rate was 1.0
ml/min and the injection volume was 3 μl (1 mg/ml). The chromatogram
was detected at 254 nm. HPLC operating conditions: HPLC system:
Agilent infinity 1260; Column: YMC pack pro C8 (YMC); Solvent: A,
deionized water, B, methanol (gradient); Flow rate: 1.0 ml/min; Monitor:
254 nm. (TIFF 77 kb)
Additional file 2: Figure S2. Magnolin inhibits migration and invasion of
cancer cells. (A) Magnolin inhibits cell migration. Human lung cancer cells,
A549 and NCI-H1975, were seeded into culture-inserts and treated with
mitomycin-C for 2 h. The culture-inserts were removed, and the cell
migration was measured using the Image J computer software program
(v. 1.45), followed by treatment with the indicated doses of magnolin for 24
h. The cell migration was photographed under an inverted microscope. (B)
Magnolin inhibits cancer cell invasion. Briefly, A549 and NCI-H1975 cells
were seeded onto the inserts of Boyden chambers and cultured overnight.
The cells were treated with the indicated concentrations of magnolin, and
cell invasion was allowed for 24 h. The migrated cells were stained with
crystal violet and observed under an inverted microscope. (TIFF 5101 kb)
Additional file 3: Figure S3. Morphology of A549 cells with magnolin
treatment. A549 lung cancer cells were treated with magnolin for 24 h as
indicated. The cell morphology was observed under an inverted
microscope. (TIFF 1528 kb)
Additional file 4: Figure S4. RSK2 regulates cell migration. (A)
Knockdown of RSK2 with RSK2 sh-RNA suppresses cell migration. A549
human lung cancer cells stably expressing sh-RNA RSK2 were seeded into
culture-inserts and treated with mitomycin-C for 2 h. The culture-inserts
were removed and cell migration was allowed for 24 h, and then cell migration
was measured using the Image J computer software program (v. 1.45). The cell
Lee et al. BMC Cancer  (2015) 15:576 Page 11 of 12migration was photographed under an inverted microscope. (B) Morphology
of A549 cells by knockdown of RSK2. A549 lung cancer cells were infected with
sh-RNA-mock or -RSK2, and the cell morphological change was observed
under an inverted microscope. (C) RSK2 deficiency attenuates EGF-induced cell
migration. RSK2+/+ and RSK2−/− MEFs were seeded into culture-inserts and
treated with mitomycin-C for 2 h. The culture-inserts were removed and cell
migration was allowed with EGF treatment for 24 h. The cell migration was
measured using the Image J computer software program (v. 1.45). The cell
migration was photographed under an inverted microscope. (TIFF 2567 kb)
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